| Product NDC: | 0115-1811 |
| Proprietary Name: | FLAVOXATE HYDROCHLORIDE |
| Non Proprietary Name: | FLAVOXATE HYDROCHLORIDE |
| Active Ingredient(s): | 100 mg/1 & nbsp; FLAVOXATE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0115-1811 |
| Labeler Name: | Global Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076234 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030828 |
| Package NDC: | 0115-1811-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0115-1811-01) |
| NDC Code | 0115-1811-01 |
| Proprietary Name | FLAVOXATE HYDROCHLORIDE |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0115-1811-01) |
| Product NDC | 0115-1811 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FLAVOXATE HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030828 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals |
| Substance Name | FLAVOXATE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |